How much B cell suppression is needed in MS?


Includes a comparison of anti-CD20 therapies (rituximab, ocrelizumab, ofatumumab), depth and duration of B cell suppression, time to B cell reconstitution, and current data on reduced-dose regimens, extended-interval dosing and personalized dosing.

14 slides

Recommend to a Colleague

Related Posts

Go back to home page